🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wenjing Zhang

University of Tennessee Health Science Center

ORCID: 0000-0002-6694-6072

Also affiliated with Xuzhou Medical College, Luye Pharma (China), Center for Cancer Research, New York University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways.

6 citations

Hanxuan Li, Xinxin Zhao, Wenjing Zhang, Guannan Zhao, Zhongzhi Wu +7 more

24 citations

Wenjing Zhang, Guannan Zhao, Zhenwen Chen, Peixin Dong, Hidemichi Watari +5 more

21 citations

Xiaofei Zhu, Philippe Gauthier, Wenjing Zhang, Adham A. Azim, George T.‐J. Huang +1 more

2 citations

Won-Young Choi, Wenjing Zhang, Francisco N. Barrera, Rachel S. Perkins, Matthew S. Jung

1 citations

Xin Liu, Whitney Barham, Kevin D. Pavelko, Susan M. Harrington, Crystal Yan Lin +10 more

1 citations

Jacob B. Hirdler, Joanina K. Gicobi, Mark Maynes, Michelle A. Hsu, Emilia R. Dellacecca +9 more